- Author:
Simon ROH
1
Author Information
- Publication Type:Case Report
- Keywords: Leiomyosarcoma; Liver; Metastasis; Neoplasm; Embolization
- MeSH: Breast; Carcinoma, Hepatocellular; Colon; Colorectal Neoplasms; Comorbidity; Esophagus; Glass; Humans; Leiomyosarcoma; Liver; Lung; Mastectomy, Segmental; Melanoma; Microspheres; Neoplasm Metastasis; Pancreas; Rectum; Sarcoma; Stomach
- From: Korean Journal of Clinical Oncology 2018;14(2):142-145
- CountryRepublic of Korea
- Language:English
- Abstract: Metastases to the liver can be found in various malignancies, most commonly originating from the colon, rectum, pancreas, stomach, esophagus, breast, lung, and melanoma. Surgical resection of liver metastasis is generally considered to be the definitive therapy fore cure. However, many patients are unable to undergo surgical resection due to medical comorbidities or multifocal extent of malignant disease affecting the liver. Among patients not eligible for surgery, other therapies exist for treatment in order to down stage the disease for surgical resection or for palliation. Radioembolization of hepatic metastases has shown to improve outcomes among patients with variety of malignancies including more common malignancies such as colorectal cancer. Yttrium-90 (Y-90) radioembolization has been successfully used in the management of hepatic metastases. A small series of metastatic sarcoma to the liver treated with radioembolization showed a promising response. We report a case of metastatic gastric leiomyosarcoma to the liver treated with Y-90 glass microspheres therapy using the radiation segmentectomy approach, previously described for hepatocellular carcinoma.